Longevity experts are mostly over Bryan Johnson's shtick and hope people consider the basics when it comes to taking care of ...

DMD treatment KER-065 showed a good safety profile in a Phase 1 clinical trial, with no serious side effects seen in healthy ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...

Collaboration to apply Lunit’s AI technologies across NCI’s broad spectrum of cancer studies, aiming to accelerate personalized cancer ...

A Penn Medicine neurologist was awarded the 2025 John Dystel Prize for his research on immune cells and how they interact to ...

European clinicians and scientists are to receive £5.5m in funding to form a world-leading research team tasked with making ...

A straightforward at-home test could potentially detect a devastating condition up to 20 years before symptoms appear, ...

Bioniq, which is renowned for its personalized nutritional supplements based on blood biomarker data, has signed up football ...

A 55p drink that is packed with probiotics has been shown in a new scientific review to improve symptoms of Alzheimer's ...

CT scan-assessed high right ventricle-left ventricle ratio of the heart predicts major adverse cardiovascular events in PH ...